Published online January 28, 2008
PEDIATRICS (doi:10.1542/10.1542/peds.2007-3638)

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Schaefer, M. K. Articles by Budnitz, D. S. Search for Related Content PubMed PubMed Citation Articles by Schaefer, M. K. Articles by Budnitz, D. S. Related Collections Office Practice Social Bookmarking                         What's this?

ARTICLE

Adverse Events Attributable to Cough and Cold Medications in Children

Melissa K. Schaefer, MD^a,b, Nadine Shehab, PharmD^a, Adam L. Cohen, MD, MPH^c and Daniel S. Budnitz, MD, MPH^a

^a Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Coordinating Center for Infectious Diseases
^b Epidemic Intelligence Service, Office of Workforce and Career Development
^c Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

BACKGROUND. Adverse drug events in children attributable to cough and cold medications have been identified as a public health issue with clinical and policy implications. Nationally representative morbidity data could be useful for targeting age-appropriate safety interventions.

OBJECTIVE. To describe emergency department visits for adverse drug events attributable to cough and cold medications in children.

METHODS. Emergency department visits for adverse drug events attributable to cough and cold medications among children aged <12 years were identified from a nationally representative stratified probability sample of 63 US emergency departments from January 1, 2004, through December 31, 2005.

RESULTS. Annually, an estimated 7091 patients aged <12 years were treated in emergency departments for adverse drug events attributable to cough and cold medications, accounting for 5.7% of emergency department visits for all medications in this age group. Most visits were for children aged 2 to 5 years (64%). Unsupervised ingestions accounted for 66% of estimated emergency department visits, which was significantly higher than unsupervised ingestions of other medications (47%), and most of these ingestions involved children aged 2 to 5 years (77%). Most children did not require admission or extended observation (93%).

CONCLUSIONS. Timely national surveillance data can help target education, enforcement, and engineering strategies for reducing adverse events attributable to cough and cold medications among children. Engineering innovations could be particularly helpful in addressing unsupervised ingestions, which is the most frequent cause of adverse events. These innovations could be applicable to other children's medications.

Key Words: adverse events • drug safety

Abbreviations: OTC—over-the-counter • FDA—Food and Drug Administration • ED—emergency department • ADE—adverse drug event • NEISS-CADES—National Electronic Injury Surveillance System–Cooperative Adverse Drug Event Surveillance • CI—confidence interval

---

Accepted Dec 11, 2007.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. Vernacchio, J. P. Kelly, D. W. Kaufman, and A. A. Mitchell Cough and Cold Medication Use by US Children, 1999-2006: Results From the Slone Survey Pediatrics, August 1, 2008; 122(2): e323 - e329. [Abstract] [Full Text] [PDF]